title: Acromegaly and associated tumours: what should gastroenterologists know?
abstract: Acromegaly is a clinical syndrome caused by the excessive production of growth hormone. It is associated with high morbidity and significantly increased mortality, mainly due to cardiovascular and respiratory complications, and cancer. Mortality is reduced to that of the general population following successful treatment, in other words, when insulin-like growth factor (IGF-I) and growth hormone values return to normal levels. Not all tumours associated with this syndrome benefit from cost-effective early diagnosis programmes. An in-depth knowledge on the part of clinicians of the morbidity and mortality associated with acromegaly, allowing them in many cases to anticipate the expected clinical course of the disease, is the best therapeutic and follow-up strategy in these patients.
authors.affiliation: Servicio de Digestivo, Hospital Zumárraga, Guipúzcoa, España. Electronic address: txaro@bizkaia.eu.
authors.forename: María Del Rosario
authors.initials: MD
authors.lastname: Calderón
authors.affiliation: Servicio de Digestivo, HUA, Álava, España.
authors.forename: Elvira
authors.initials: E
authors.lastname: Delgado
authors.affiliation: Servicio de Digestivo, Policlínica San José, Álava, España.
authors.forename: Francisco
authors.initials: F
authors.lastname: García Campos
mesh_terms: D000172:Acromegaly / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D000465:Algorithms; D005762:Gastroenterology; D005770:Gastrointestinal Neoplasms / Q000209:etiology*; D006801:Humans
keywords: Acromegalia; Acromegaly; Adenomas colorrectales; Colorectal adenoma; Colorectal cancer; Cáncer colorrectal; Growth hormone; Hormona del crecimiento; Neoplasias; Neoplasms